April 12, 2023
Executive Profile
43
4
Christi Shaw, this year’s Healthcare Businesswomen’s Association (HBA) Woman of the Year, stays true to her beliefs—and life mission—of helping others.
April 12, 2023
Executive Roundtable
43
4
Marketing leaders discuss the powerful role life sciences companies can play in the expanding digital landscape for healthcare communications—as “one of the helpful voices” in driving the customer and patient conversations that matter most.
April 12, 2023
Feature
43
4
It’s time for pharma brands to recognize the potential of TikTok as a promotional platform and develop a strategy to not only stand out but make an impact.
April 11, 2023
Feature
43
4
After the pandemic forced fundamental changes in the ways pharma and key opinion leaders worked together, both groups are using what they learned for a more seamless connection.
April 11, 2023
Feature
43
4
What Smita Pillai, chief DEI officer, Regeneron, learned from two decades in DE&I roles.
April 11, 2023
Columns
43
4
Over two years into a bear market, it still can’t catch a sustainable bid.
April 10, 2023
Columns
43
4
Taking stock as the Orphan Drug Act hits its 40-year anniversary.
April 10, 2023
Columns
43
4
Shift focus in orphan and ultra-orphan messaging to clinical benefit.
April 10, 2023
Columns
43
4
The time is ripe to double down on local “market-fit” capabilities.
April 09, 2023
Columns
43
4
US pharma industry handcuffed by restrictions, group argues.
April 09, 2023
Backpage
43
4
Regardless of engagement mode pursued, personalization is the key.
April 09, 2023
Issue PDF
43
4
Click the title above for a link to open the Pharmaceutical Executive April 2023 issue in an interactive PDF format.